This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Guangzhou Cas Lamvac Biotech Co., Ltd, Guangzhou Reforgene Medicine Co., Ltd., Zhejiang Synsorbio Technology Co., Ltd.. Active years: 2022-2026.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2022-2026
Title: Innovations of Xingxiang Liang in Biotech
Introduction
Xingxiang Liang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the area of attenuation systems for plasmodia. His innovative work has the potential to impact various applications in health and disease management.
Latest Patents
Xingxiang Liang holds a patent for an "Attenuation system and use thereof." This patent discloses an attenuation system specifically designed for attenuating plasmodia. The system utilizes an EF1g gene to regulate the expression or degradation of the gene, thereby controlling the growth of plasmodia and achieving effective attenuation.
Career Highlights
Liang's career is marked by his dedication to research and innovation in biotechnology. He has successfully developed a unique approach to managing plasmodia, which could lead to advancements in medical treatments and therapies.
Collaborations
Xingxiang Liang collaborates with talented individuals in his field, including Ying Tong and Yongchao Yao. Their combined expertise enhances the research and development efforts at Guangzhou Cas Lamvac Biotech Co., Ltd.
Conclusion
Xingxiang Liang's contributions to biotechnology through his innovative patent demonstrate his commitment to advancing scientific knowledge and improving health outcomes. His work exemplifies the importance of innovation in addressing complex biological challenges.